SCHEMBL9850107

SCHEMBL9850107

O=C(Nc1ncnc2c1ncn2[C@@H]1O[C@H](COC(=O)c2ccccc2)[C@@H](OC(=O)c2ccccc2)[C@H]1F)c1ccccc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.56
▸ P2RX3 P56373 2/20 0.51
▸ P2RX4 Q99571 2/20 0.51
▸ P2RX2 Q9UBL9 2/20 0.51
▸ PRMT6 Q96LA8 1/20 0.49
▸ P2RY12 Q9H244 3/20 0.48
▸ ENPP1 P22413 1/20 0.48
▸ PRKAB2 O43741 1/20 0.46
▸ PRKAG1 P54619 1/20 0.46
▸ PRKAA2 P54646 1/20 0.46
▸ PRKAA1 Q13131 1/20 0.46
▸ PRKAG3 Q9UGI9 1/20 0.46
▸ PRKAG2 Q9UGJ0 1/20 0.46
▸ PRKAB1 Q9Y478 1/20 0.46
▸ P2RY2 P41231 1/20 0.46
▸ P2RY1 P47900 1/20 0.46
▸ P2RY6 Q15077 1/20 0.46
▸ ABCB1 P08183 1/20 0.45
▸ DNPH1 O43598 1/20 0.45
▸ MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9850105 1.00 LMNA (0.56) LMNAP2RX3P2RX4P2RX2PRMT6
SCHEMBL13975682 1.00 LMNA (0.56) LMNAP2RX3P2RX4P2RX2PRMT6
SCHEMBL21245357 0.93 LMNA (0.58) LMNAP2RX3P2RX4P2RX2PRMT6
SCHEMBL22983997 0.93 P2RX3 (0.59) LMNAP2RX3P2RX4P2RX2PRMT6
SCHEMBL21750474 0.92 PRMT6 (0.50) LMNAP2RX3P2RX4P2RX2PRMT6
SCHEMBL21750476 0.92 PRMT6 (0.50) LMNAP2RX3P2RX4P2RX2PRMT6
SCHEMBL13396711 0.92 PRMT6 (0.50) LMNAP2RX3P2RX4P2RX2PRMT6
SCHEMBL13396713 0.91 PRMT6 (0.51) LMNAP2RX3P2RX4P2RX2PRMT6
SCHEMBL30019683 0.89 LMNA (0.48) LMNAP2RX3P2RX4P2RX2ENPP1
SCHEMBL23169729 0.89 LMNA (0.57) LMNAPRMT6P2RY12P2RY2P2RY1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0428109-A2 Deoxyfluoronucleoside process Bristol-Myers Squibb Company (US) 1991-05-22 — — EP disclosed
Send feedback